PS
ARKG icon

Principal Securities’s ARK Genomic Revolution ETF ARKG Stock Holding History

Principal Securities’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-753
Closed -$20.9K – 1468
2025
Q3 		$20.9K Buy
753
+743
+7,430% +$18.8K ﹤0.01% 2382
2025
Q2 		$244 Buy
+10
New +$219 ﹤0.01% 3580
2024
Q4 		– Sell
-377
Closed -$9.65K – 3550
2024
Q3 		$9.65K Sell
377
-5
-1% -$127 ﹤0.01% 2455
2024
Q2 		$8.97K Sell
382
-600
-61% -$15.1K ﹤0.01% 2446
2024
Q1 		$28.2K Hold
982
– – ﹤0.01% 1833
2023
Q4 		$32.2K Buy
+982
New +$26.7K ﹤0.01% 1682

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Principal Securities's ARKG Position: Q4 2025 in Review

Principal Securities sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 753 shares — an estimated $20.9K sold.

Principal Securities first reported a position in ARKG in Q4 2023 and held it in 6 quarters. The position peaked at $32.2K in Q4 2023. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Principal Securities reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 753 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $20.9K.
  • Principal Securities first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 6 quarters.
  • Principal Securities's ARK Genomic Revolution ETF position peaked at $32.2K in Q4 2023.
  • 238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.